ClinicalTrials.gg
Active, not recruitingNCT07925723ALAS PROPIASUpdated Nov 9, 2026

ALAS PROPIAS: Music Therapy for Women Experiencing Machista Violence in Intimate Partner Relationships

An interventional study of Experimental Group (ALAS PROPIAS) in Intimate Partner Violence (IPV) and Intimate Partner Violence Against Women, sponsored by Universidad Miguel Hernandez de Elche. Active, not recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Universidad Miguel Hernandez de Elche · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Feb 2026, registered Nov 2026).
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The ALAS PROPIAS program evaluates the impact of a 12-session group active music therapy intervention on the well-being and psychological health of women experiencing machista violence in intimate partner relationships who are receiving support through specialised care and intervention programmes, including shelter services. Using a quasi-experimental design with an intervention group and a wait-list control group, the study examines changes in mood, self-esteem, anxiety, depression, psychological well-being, and quality of life among participants.

Read the detailed description

The ALAS PROPIAS program is a study designed to evaluate the effects of group active music therapy on the well-being and psychological health of women experiencing machista violence in intimate partner relationships. The intervention consists of 12 group music therapy sessions delivered to women receiving support through specialised care and intervention programmes, including shelter services.

The study follows a quasi-experimental, controlled, non-randomised, longitudinal pretest-posttest design with a wait-list control group. Changes in participants' mood, self-esteem, anxiety, depression, psychological well-being, and quality of life are assessed to explore the potential contribution of group active music therapy in this context.

02

Conditions studied

  • Intimate Partner Violence (IPV)
  • Intimate Partner Violence Against Women

Browse trials for

Keywords

  • Music Therapy
  • Machista Violence
  • Psychological Well-Being
  • Quality of Life
  • Anxiety
  • Depression
03

In context

Psychological Well-Being Unverified

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's enrollment of 67 is below the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Universidad Miguel Hernandez de Elche is the lead sponsor of 87 studies on the registry; 16 are open to participants now.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years or older.
  • Women experiencing machista violence in intimate partner relationships.
  • Women receiving support through specialised care and intervention programs, including shelter services.

Exclusion criteria

Exclusion Criteria:

  • No exclusion criteria.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Experimental Group (ALAS PROPIAS)

    Participants receive the ALAS PROPIAS program, consisting of 12 group active music therapy sessions, and complete the study assessments before and after the intervention.

    Behavioral: Experimental Group (ALAS PROPIAS)

  • No intervention
    Control Group (Waitlist)

    Participants remain on a waitlist during the comparison period. Study assessments are conducted before and after this period; post-test data collection is ongoing.

Interventions

  • BehavioralExperimental Group (ALAS PROPIAS)

    The ALAS PROPIAS intervention consists of 12 group active music therapy sessions delivered to women experiencing machista violence in intimate partner relationships who are receiving support through specialised care and intervention programmes, including shelter services. The intervention follows a predefined protocol of musical activities and techniques, implemented consistently across all participating centres. The programme aims to evaluate changes in participants' mood, self-esteem, anxiety, depression, psychological well-being, and quality of life.

06

What researchers measure

Primary outcomes

  1. Change in Self-Esteem

    Change in self-esteem from pre-test to post-test, measured using the Rosenberg Self-Esteem Scale in both the experimental group and the wait-list control group.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  2. Change in Anxiety

    Change in anxiety from pre-test to post-test, measured using the State-Trait Anxiety Inventory (STAI) in both the experimental group and the wait-list control group.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  3. Change in Depression

    Change in depression from pre-test to post-test, measured using the Beck Depression Inventory-II (BDI-II) in both the experimental group and the wait-list control group.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  4. Change in Psychological Well-Being

    Change in psychological well-being from pre-test to post-test, measured using the Ryff Psychological Well-Being Scales in both the experimental group and the wait-list control group.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  5. Change in Quality of Life

    Change in quality of life from pre-test to post-test, measured using the GENCAT Quality of Life Scale in both the experimental group and the wait-list control group.

    Time frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

  6. Changes in Mood-Related Indicators During the Music Therapy Intervention

    Changes in mood-related indicators are assessed in the experimental group throughout the 12-session group active music therapy intervention. The researcher uses a structured observational recording tool to document indicators associated with six emotional states: sadness, anger, shame, insecurity, fear, and happiness. The indicators include participants' verbal expressions, facial expressions, posture, vocal characteristics, participation in musical activities, and interactions with other group members. In addition, participants complete the Self-Assessment Manikin (SAM) at the beginning and end of each session to assess their momentary affective responses

    Time frame: At the beginning and end of each of the 12 music therapy sessions for the SAM; at the end of each session for the researcher's observational recording tool.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the primary and secondary outcomes will be made available to qualified researchers upon reasonable request submitted to the principal investigator. Data sharing will be subject to ethical review, a formal data-sharing agreement, and strict compliance with European Union GDPR regulations to safeguard minor participants' confidentiality.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will become available after the primary manuscript publishing the final longitudinal findings is accepted

Access criteria: Individual participant data will not be publicly shared to protect minor participants' confidentiality in compliance with GDPR and local data protection regulations. Aggregate data and protocol materials are available upon request

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925723
Lead sponsor
Universidad Miguel Hernandez de Elche
Responsible party
Eva Maria Leon Zarceño (Associate Professor, Universidad Miguel Hernandez de Elche) — Principal investigator
First posted
Nov 9, 2026
Start date
Feb 10, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Nov 9, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion